Appraisal of a Simple and Effective RT-qPCR Assay for Evaluating the Reverse Transcriptase Activity in Blood Samples from HIV-1 Patients

Testing HIV-1 RNA in plasma by PCR is universally accepted as the ultimate standard to confirm diagnosis of HIV-1 infection and to monitor viral load in patients under treatment. However, in some cases, this assay could either underestimate or overestimate the replication capacity of a circulating or latent virus. In the present study, we performed the assessment of evaluating the HIV-1 reverse transcriptase (RT) activity by means of a new assay for the functional screening of the status of HIV-1 patients. To this purpose, we utilized, for the first time on blood samples, an adapted version of a real-time RT quantitative PCR assay, utilized to evaluate the HIV-1-RT inhibitory activity of compounds. The study analyzed blood samples from 28 HIV-1-infected patients, exhibiting a wide range of viremia and immunological values. Results demonstrated that plasma HIV-1 RT levels, expressed as cycle threshold values obtained with the assay under appraisal, were inversely and highly significantly correlated with the plasma HIV-1-RNA levels of the patients. Thus, an HIV-1 RT quantitative PCR assay was created which we describe in this study, and it may be considered as a promising basis for an additional tool capable of furnishing information on the functional virological status of HIV-1-infected patients.

[1]  S. L. Le Grice,et al.  Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities , 2019, Current HIV research.

[2]  J. DeStefano,et al.  A highly sensitive aptamer-based HIV reverse transcriptase detection assay. , 2018, Journal of virological methods.

[3]  Jeffrey M. Gerold,et al.  Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane , 2018, Proceedings of the National Academy of Sciences.

[4]  A. Mastino,et al.  Development and evaluation of a simple and effective RT-qPCR inhibitory assay for detection of the efficacy of compounds towards HIV reverse transcriptase , 2017, Applied Microbiology and Biotechnology.

[5]  S. Grelli,et al.  Quantification of HTLV-1 reverse transcriptase activity in ATL patients treated with zidovudine and interferon-α. , 2017, Blood advances.

[6]  A. Mastino,et al.  A novel, cell‐free PCR‐based assay for evaluating the inhibitory activity of antiretroviral compounds against HIV reverse transcriptase , 2014, Journal of medical virology.

[7]  B. Verhasselt,et al.  Quantification of Reverse Transcriptase Activity by Real-Time PCR as a Fast and Accurate Method for Titration of HIV, Lenti- and Retroviral Vectors , 2012, PloS one.

[8]  F. Martin,et al.  Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors , 2011, Viruses.

[9]  S. Lewin,et al.  A novel, rapid method to detect infectious HIV-1 from plasma of persons infected with HIV-1. , 2010, Journal of virological methods.

[10]  M. Mcclure,et al.  A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. , 2009, Journal of virological methods.

[11]  T. Leitner,et al.  Improved HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2005, Journal of medical virology.

[12]  J. Hocking,et al.  Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. , 2005, Current HIV research.

[13]  Beda Joos,et al.  Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. , 2004, Virology.

[14]  T. Leitner,et al.  HIV‐1 viral load determination based on reverse transcriptase activity recovered from human plasma , 2003, Journal of medical virology.

[15]  M. Ciotti,et al.  Protection by Herpes Simplex Virus Glycoprotein D against Fas-mediated Apoptosis , 2003, Journal of Biological Chemistry.

[16]  Kent J Weinhold,et al.  Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control. , 2003, The Journal of infectious diseases.

[17]  J. Sears,et al.  Single-tube fluorescent product-enhanced reverse transcriptase assay with Ampliwax (STF-PERT) for retrovirus quantitation. , 2003, Journal of virological methods.

[18]  J. Palacín,et al.  The expanded suprapubic area as a skin donor site in the treatment of congenital absence of the vagina. , 2000, Plastic and reconstructive surgery.

[19]  A. Shepherd,et al.  High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods. , 1999, Journal of virological methods.

[20]  J. Böni,et al.  Sensitive detection and quantification of particle‐associated reverse transcriptase in plasma of HIV‐1‐infected individuals by the product‐enhanced reverse transcriptase (PERT) assay , 1996, Journal of medical virology.

[21]  W. Heneine,et al.  Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1. , 1995, The Journal of infectious diseases.

[22]  J. Kappes,et al.  Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases) , 1994, Journal of clinical microbiology.

[23]  J. Böni,et al.  Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Silver,et al.  An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. , 1993, Nucleic acids research.

[25]  J. Eberle,et al.  A new method for measuring reverse transcriptase activity by ELISA. , 1992, Journal of virological methods.

[26]  M. Andreoni,et al.  Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma , 1992, Journal of medical virology.

[27]  Á. Gyuris,et al.  A solid phase reverse transcriptase micro-assay for the detection of human immunodeficiency virus and other retroviruses in cell culture supernatants. , 1990, Journal of virological methods.

[28]  A. Collier,et al.  Plasma viremia in human immunodeficiency virus infection. , 1989, The New England journal of medicine.